Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1998-1-14
|
pubmed:abstractText |
Rap1-GAP protein has been identified as an inactivator of Rap1 activity, a putative endogenous antagonist of Ras proteins. The Rap1-GA1 locus maps to 1p36.1-35, the region which may harbor a gene for familial melanoma. In the present immunohistochemical study we analyzed the clinicopathological and prognostic relevance of Rap1-GAP expression in 60 benign and 103 malignant melanocytic tumors. Cytoplasmic immunoreactivity was detected in the cells of 27/60 nevi (45%) and 59/103 melanomas (57%). In the latter group the frequency of Rap1-GAP expression increased (P < 0.05) with the thickness of primary tumors and was highest in metastatic lesions. Rap1-GAP protein was detected in 15/19 subsequently recurring primary melanomas (79%) but only in 32/67 tumors (47%) of patients who remained free of disease (P < 0.05) for at least 6 years. Five out of six recurring thin melanomas (< 2 mm) were found to be immunoreactive. Although being no indicator for malignant transformation of melanocytic lesions, Rap1-GAP overexpression may represent a useful marker for identifying thin high-risk melanomas. Cytoplasmic expression of Rap1-GAP has also been observed in the cells of skin appendages and in keratinocytes, particularly in suprabasal layers of the epidermis. Therefore, Rap1-GAP is likely to be associated with cellular growth and/or differentiation. However, the present study did not provide evidence that this gene, despite its chromosomal localization, represents an early melanoma gene.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/GTPase-Activating Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RAP1GAP protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/rap GTP-Binding Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0340-3696
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
289
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
573-7
|
pubmed:dateRevised |
2008-5-14
|
pubmed:meshHeading |
pubmed-meshheading:9373716-GTP-Binding Proteins,
pubmed-meshheading:9373716-GTPase-Activating Proteins,
pubmed-meshheading:9373716-Humans,
pubmed-meshheading:9373716-Immunohistochemistry,
pubmed-meshheading:9373716-Melanocytes,
pubmed-meshheading:9373716-Melanoma,
pubmed-meshheading:9373716-Nevus,
pubmed-meshheading:9373716-Proteins,
pubmed-meshheading:9373716-Skin Neoplasms,
pubmed-meshheading:9373716-Tumor Markers, Biological,
pubmed-meshheading:9373716-rap GTP-Binding Proteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
Clinicopathological and prognostic relevance of Rap1-GAP expression in melanocytic tumors.
|
pubmed:affiliation |
Department of Dermatology, Hannover Medical School, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|